Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum

Ähnliche Einträge

• The Aspergillus galactomannan Ag VIRCLIA® Monotest and the sõna Aspergillus galactomannan lateral flow assay show comparable performance for the diagnosis of invasive aspergillosis
  von: Corinna Küpper, et al.
  Veröffentlicht: (2024)
• Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?
  von: Rémy Gerard, et al.
  Veröffentlicht: (2024)
• Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study
  von: Anuj Ajayababu, et al.
  Veröffentlicht: (2024)
• Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associated pulmonary aspergillosis: Cross‐sectional and systematic review of literature
  von: Arthur Pereira dos Santos, et al.
  Veröffentlicht: (2024)
• The role of surgery for invasive pulmonary aspergillosis in paediatric hemato‐oncology patients—Can we better define it?
  von: Mohamed Hassan, et al.
  Veröffentlicht: (2024)